Atlas Trials

Embolization of the Middle Meningeal Artery for the Prevention of Chronic Subdural Hematoma Recurrence in High Risk Patients (EMPROTECT)

Clinical trial NCT04372147 · COMPLETED

Trial details

NCT number
NCT04372147
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Subdural HematomaAt Risk of Post-operative RecurrenceBurr-hole Surgery
Start date
2020-06-22
Primary completion
2023-10-23
Enrollment
342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.